Virtual Medicinal Product (VMP) - Omalizumab 150mg powder and solvent for solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Omalizumab 150mg powder and solvent for solution for injection vials Start Date 09-11-2005 End Date
Abbreviated Name Abbreviated Name Omalizumab 150mg inj vials Start Date 01-05-2009
Previous Abbreviated Name Omalizumab 150mg pdr & solv for soln for inj vials Previous Start Date 09-11-2005 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Subcutaneous
Form
Powder and solvent for solution for injection
Ontology Form/Route
solutioninjection.subcutaneous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
R03DX05
BNF Start Date End Date
Current BNF 03040200 Start Date 04-04-2022 End Date
Previous BNF 03030200 Start Date 04-05-2006 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
9742911000001102 09-11-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Omalizumab Based on Ingredient Substance 150 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial